A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of SAL003 in Combination With Statin Therapy in Patients With Hypercholesterolemia and Mixed Dyslipidemia
Clinical trial NCT07253584 · COMPLETED
Trial details
- NCT number
- NCT07253584
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-19
- Primary completion
- 2025-06-23
- Enrollment
- 720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.